Quality of Life in Patients With Difficult-to-Treat Basal Cell Carcinoma: An Evaluation of Impact and Surgical Outcomes.

RecruitingOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Basal Cell Carcinoma
Interventions
OTHER

Patient-reported outcome measures (PROMs)

Administration of questionnaires investigating the impact of facial difficult-to-treat basal cell carcinoma treated by surgery on patient's quality of life over the course of one year. The questionnaires will be submitted at baseline (i.e., before surgery) and at 3-months follow up.

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER